Indian researchers who don't appear to be investigating human medicine dedicating a full paragraph of their paper to an explication of Brilacidin. The simple fact that they are aware of the compound and its potential as an antiviral (and specifically SARS-CoV-2) is, to me, intriguing. Or it could be of little consequence as I originally prefaced.
I take umbrage to ascribing prestige to the journal as a means of artificially elevating the stature of its contents . I find it as annoying as those who misapply and misinterpret clinical trials protocols and procedures simply to conform to their misbegotten ideas of how things should be, as opposed to objective truth.
News 
Market Data 
Discover 
AI
